Addex Therapeutics Financial Overview
Addex Therapeutics's market cap is currently $9.81M. The company's EPS TTM is $-0.01; its P/E ratio is -0.99; Addex Therapeutics is scheduled to report earnings on December 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
